ConductScience.org, home

Paper · 22856463

References37

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
120970670Reactivations of cytomegalovirus, human herpes virus 6, and Epstein-Barr virus differ with respect to risk factors and clinical outcome after hematopoietic stem cell transplantation.Transplant Proc2010https://conductscience.org/library/papers/20970670PubMed
219264919Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation.Blood2009https://conductscience.org/library/papers/19264919PubMed
321997849Cytomegalovirus infection and disease after allogeneic hematopoietic stem cell transplantation: experience in a center with a high seroprevalence of both CMV and hepatitis B virus.Ann Hematol2012https://conductscience.org/library/papers/21997849PubMed
420482561Prospective study of infectious complications in allogeneic hematopoietic stem cell transplant recipients.Clin Transplant2011https://conductscience.org/library/papers/20482561PubMed
511801465Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.Haematologica2002https://conductscience.org/library/papers/11801465PubMed
611157478Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation.Blood2001https://conductscience.org/library/papers/11157478PubMed
717448963Risk assessment in haematopoietic stem cell transplantation: conditioning.Best Pract Res Clin Haematol2007https://conductscience.org/library/papers/17448963PubMed
819497070Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction.Transpl Infect Dis2009https://conductscience.org/library/papers/19497070PubMed
917921853Human herpesvirus 6 (HHV-6)-associated pleurisy after unrelated cord blood transplantation in children with chemotherapy-resistant malignant Lymphoma.J Pediatr Hematol Oncol2007https://conductscience.org/library/papers/17921853PubMed
1022424172Allogeneic hematopoietic stem cell transplantation in China: where we are and where to go.J Hematol Oncol2012https://conductscience.org/library/papers/22424172PubMed
1114576063Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responses.Blood2004https://conductscience.org/library/papers/14576063PubMed
1211877269Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study.Blood2002https://conductscience.org/library/papers/11877269PubMed
1319043458Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia.Bone Marrow Transplant2009https://conductscience.org/library/papers/19043458PubMed
148652385
A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Br J Haematol1996https://conductscience.org/library/papers/8652385PubMed
1521323694The impact of early viral infections and graft-versus-host disease on immune reconstitution following paediatric stem cell transplantation.Scand J Immunol2011https://conductscience.org/library/papers/21323694PubMed
1616151426Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time.Bone Marrow Transplant2005https://conductscience.org/library/papers/16151426PubMed
1715090449
Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation.
Blood2004https://conductscience.org/library/papers/15090449PubMed
1822856463Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies.J Hematol Oncol2012https://conductscience.org/library/papers/22856463PubMed
1912171713Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.Cytotherapy2001https://conductscience.org/library/papers/12171713PubMed
2018300756Novel strategies for relapsed and refractory acute myeloid leukemia.Curr Opin Hematol2008https://conductscience.org/library/papers/18300756PubMed

papers-2026-11-12-0.1.0

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/papers/v1/22856463/references